Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab maintenance in metastatic colorectal cancer
NCT00544700Phase 3Terminated
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Nov 2007
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colorectal cancer (metastatic) (mCRC), sponsored by Swiss Group for Clinical Cancer Research. Started Nov 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00544700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544700.